Author:
Xiao Xianhong,Zhang Qiang
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Parola M, Pinzani M (2019) Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37–55
2. Higashi T, Friedman SL, Hoshida Y (2017) Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 121:27–42
3. Cheng Q, Li C, Yang CF et al (2019) Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-beta1/Smad and NOX4/ROS pathways. Chem Biol Interact 299:131–139
4. Li H, Lan J, Han C et al (2018) Brg1 promotes liver fibrosis via activation of hepatic stellate cells. Exp Cell Res 364(2):191–197
5. Zhou X, Ke C, Lv Y et al (2020) Asiaticoside suppresses cell proliferation by inhibiting the NFkappaB signaling pathway in colorectal cancer. Int J Mol Med 46(4):1525–1537
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献